Evidence map›Paper›PMID 36900390›Full record

ArticleCancers2023

A Biterm Topic Model for Sparse Mutation Data.

Itay Sason, Yuexi Chen, Mark D M Leiserson, Roded Sharan

Full text read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Itay SasonSchool of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel.
Yuexi ChenDepartment of Computer Science and Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD 20740, USA.
Mark D M LeisersonDepartment of Computer Science and Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD 20740, USA.
Roded SharanSchool of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0001-8363-4882

Funding

United States-Israel Binational Science Foundation 2019336
6 · The paper itself

Abstract

Mutational signature analysis promises to reveal the processes that shape cancer genomes for applications in diagnosis and therapy. However, most current methods are geared toward rich mutation data that has been extracted from whole-genome or whole-exome sequencing. Methods that process sparse mutation data typically found in practice are only in the earliest stages of development. In particular, we previously developed the Mix model that clusters samples to handle data sparsity. However, the Mix model had two hyper-parameters, including the number of signatures and the number of clusters, that were very costly to learn. Therefore, we devised a new method that was several orders-of-magnitude more efficient for handling sparse data, was based on mutation co-occurrences, and imitated word co-occurrence analyses of Twitter texts. We showed that the model produced significantly improved hyper-parameter estimates that led to higher likelihoods of discovering overlooked data and had better correspondence with known signatures.

Indexed as

biterm topic modelmutational signaturepanel sequencing data

Identifiers

PMID36900390
PMCPMC10000560

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read9
table measurements read7
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.